Dr. Reddy’s and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593)
Significant reduction in HbA1c with Balaglitazone and improved safety profile.
Significant reduction in HbA1c with Balaglitazone and improved safety profile.
Dr. Reddy's Laboratories Ltd. has announced that it has joined the Green Chemistry Institute Pharmaceutical Roundtable of the American Chemical Society (ACS) as an Associate member.
Dr. Reddy's Laboratories will announce results for the Second quarter ended 30 September 2009 on Friday, 23 October 2009 after the Board Meeting.
The new range of Softbox Silverpod provide pharmaceutical companies with the first real option to using "Active" Air Container systems for shipping bulk manufactured temperature sensitive products. Four of the world's top ten pharmaceutical companies have already implemented these new systems to realise significant cost benefit whilst at the same time eliminating temperature excursions.
mondoBIOTECH and Bachem on 24 September announced the conclusion of a longterm cooperation.
Breakthrough crystallisation technology for protein structure determination.
Integrating structural biology and medicinal chemistry.
We continue to update and extend our capabilities by adding techniques and instruments which enhance our ability to accomodate customer needs. The growing number of transition metal-assisted transformations applied within API manufacture, and an ever increasing demand to characterise also minor impurities, e. g. associated with potential genotox concerns, have triggered two recent investments.
Synectix Pharmaceutical Solutions Ltd, the speciality drug development company, announced today that effective immediately, the company has changed its name to Kuecept Ltd.